Thermo Fisher Scientific Inc. news

   Watch this stock
Showing stories 1 - 10 of about 32   

Articles published

TMO 158.82 -0.08 (-0.05%)
price chart
FTIR Spectrometer
MADISON, Wis., May 7, 2012 - Thermo Fisher Scientific Inc. has introduced the Nicolet iS50, a Fourier transform infrared (FTIR) research-grade spectrometer with one-touch operation.
Thermo Fisher Scientific TRACE 1300 Series GC gas chromatography system ...
Thermo Fisher Scientific Inc., the world leader in serving science, is featuring the Thermo Scientific TRACE 1300 Series GC during ASMS 2012.
Thermo Scientific launches Nicolet iS50 FT-IR spectrometer
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Nicolet iS50 FT-IR spectrometer, the first research-grade FT-IR with one-touch operation.
The Thermo Scientific Nicolet iS50 FT-IR - Product Spotlight
The Thermo Scientific Nicolet iS50 FT-IR can be supplied as a stand-alone system with a range of accessories and upgrades available.
Thermo Fisher Introduces Gold-Plate Detection Technology
Thermo Fisher Scientific Inc., Billerica, Mass., has introduced its Thermo Scientific Au/Gold Detection & Identification Technology (AuDIT), a patent-pending software feature designed to help gold buyers meet the challenge of identifying gold-plated items.
Goldman-Bred Neuroscientist Tracks Testosterone Trading
Though Scott is a fictional representation, his symptoms are all too real, judging from the observations of Coates, who spent 12 years trading derivatives for Goldman Sachs Group Inc., Merrill Lynch & Co. and Deutsche Bank AG. “As losses mount on the ...
Improved Metal Detection Technologies Play a Role in New Food Safety Systems
"Metal detectors continue to be commercially viable because the technology provides an affordable contamination detection tool, regardless of company size," says Bob Ries, lead product manager for metal detection at Thermo Fisher Scientific Food ...
RBC, JPMorgan, Natixis Said to Arrange Global Blue LBO Debt
The acquisition loans will account for 3.5 times Global Blue's earnings before interest, tax, depreciation and amortization, or about 40 percent of the company's value, according to three people who declined to be identified because the deal is private.
Opexa's Tovaxin for MS is now Tcelna
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company is rebranding its leading MS therapy with the new name TcelnaTM. The product ...
TransForce Sales Goal Pivots on New US Acquisitions
Acquisitions are part of Bedard's push to remake Canada's largest trucker into a continent-wide company selling transport, logistics and energy services.